Literature DB >> 31663272

Pyoderma gangrenosum at multiple sites in a post-colostomy ulcerative colitis patient with chronic hepatitis B virus: A case report.

Ben Wang1, Ting Liu1, Fang Liu1, Yan-Ling He1.   

Abstract

Pyoderma gangrenosum is an uncommon ulcerative cutaneous lesion manifesting as rapidly progressing single or multiple skin ulcers. Permanent stoma in inflammatory bowel disease patients remains an independent risk of pyoderma gangrenosum. In the current report, we describe a case of pyoderma gangrenosum in a post-colostomy ulcerative colitis patient with chronic hepatitis B. Pyoderma gangrenosum began seemingly as peristomal dermatitis that rapidly developed into painful ulcerations with subsequent appearance of sterile pustules and ulcerations in the left lower leg. The patient significantly improved after active management with prednisolone, antiviral therapy with entecavir, and wound dressings. Our case suggests that physicians and surgeons should have a high index of suspicion of pyoderma gangrenosum in post-colostomy ulcerative colitis patients who develop peristomal dermatitis.
© 2019 Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Entities:  

Keywords:  hepatitis B virus; post-colostomy ulcerative colitis; pyoderma gangrenosum

Mesh:

Substances:

Year:  2019        PMID: 31663272      PMCID: PMC7948590          DOI: 10.1111/iwj.13255

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  10 in total

1.  Successful treatment of severe pyoderma gangrenosum with pimecrolimus cream 1%.

Authors:  V Bellini; S Simonetti; P Lisi
Journal:  J Eur Acad Dermatol Venereol       Date:  2008-01       Impact factor: 6.166

2.  The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.

Authors:  C N Bernstein; J F Blanchard; P Rawsthorne; N Yu
Journal:  Am J Gastroenterol       Date:  2001-04       Impact factor: 10.864

Review 3.  [Pyoderma gangrenosum].

Authors:  K Herberger
Journal:  Hautarzt       Date:  2016-09       Impact factor: 0.751

Review 4.  Trends in the Association between Pyoderma Gangrenosum and Autoimmune Hepatitis: Case Report and Review of the Literature.

Authors:  Heidi Wat; Richard M Haber
Journal:  J Cutan Med Surg       Date:  2014-10       Impact factor: 2.092

5.  Diagnosis and management of peristomal pyoderma gangrenosum: A systematic review.

Authors:  Ladan Afifi; Isabelle M Sanchez; Matthew M Wallace; Sara F Braswell; Alex G Ortega-Loayza; Kanade Shinkai
Journal:  J Am Acad Dermatol       Date:  2017-12-27       Impact factor: 11.527

Review 6.  Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment.

Authors:  Afsaneh Alavi; Lars E French; Mark D Davis; Alain Brassard; Robert S Kirsner
Journal:  Am J Clin Dermatol       Date:  2017-06       Impact factor: 7.403

Review 7.  Ulcerative colitis.

Authors:  Ryan Ungaro; Saurabh Mehandru; Patrick B Allen; Laurent Peyrin-Biroulet; Jean-Frédéric Colombel
Journal:  Lancet       Date:  2016-12-01       Impact factor: 79.321

8.  Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients.

Authors:  David Farhi; Jacques Cosnes; Nada Zizi; Olivier Chosidow; Philippe Seksik; Laurent Beaugerie; Selim Aractingi; Kiarash Khosrotehrani
Journal:  Medicine (Baltimore)       Date:  2008-09       Impact factor: 1.889

9.  Pyoderma gangrenosum at multiple sites in a post-colostomy ulcerative colitis patient with chronic hepatitis B virus: A case report.

Authors:  Ben Wang; Ting Liu; Fang Liu; Yan-Ling He
Journal:  Int Wound J       Date:  2019-10-29       Impact factor: 3.315

10.  Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease.

Authors:  Yoram Menachem; Israel Gotsman
Journal:  Isr Med Assoc J       Date:  2004-02       Impact factor: 0.892

  10 in total
  1 in total

1.  Pyoderma gangrenosum at multiple sites in a post-colostomy ulcerative colitis patient with chronic hepatitis B virus: A case report.

Authors:  Ben Wang; Ting Liu; Fang Liu; Yan-Ling He
Journal:  Int Wound J       Date:  2019-10-29       Impact factor: 3.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.